FI905294A0 - Substituerade cykloalkano/b/ dihydroindol- och indolsulfonamider. - Google Patents

Substituerade cykloalkano/b/ dihydroindol- och indolsulfonamider.

Info

Publication number
FI905294A0
FI905294A0 FI905294A FI905294A FI905294A0 FI 905294 A0 FI905294 A0 FI 905294A0 FI 905294 A FI905294 A FI 905294A FI 905294 A FI905294 A FI 905294A FI 905294 A0 FI905294 A0 FI 905294A0
Authority
FI
Finland
Prior art keywords
indolsulfonamider
cykloalkano
substituerade
dihydroindol
och
Prior art date
Application number
FI905294A
Other languages
English (en)
Inventor
Horst Boeshagen
Ulrich Mueller
Ulrich Rosentreter
Erwin Bischoff
Volker-Bernd Fiedler
Elisabeth Perzborn
Joachim Huetter
Peter Norman
Nigel J Cuthbert
Hilary P Francis
Marie G Mckenniff
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI905294A0 publication Critical patent/FI905294A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI905294A 1989-10-30 1990-10-26 Substituerade cykloalkano/b/ dihydroindol- och indolsulfonamider. FI905294A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898924392A GB8924392D0 (en) 1989-10-30 1989-10-30 Substituted cycloalkano/b/dihydroindole-and-indolesulphonamides

Publications (1)

Publication Number Publication Date
FI905294A0 true FI905294A0 (fi) 1990-10-26

Family

ID=10665396

Family Applications (1)

Application Number Title Priority Date Filing Date
FI905294A FI905294A0 (fi) 1989-10-30 1990-10-26 Substituerade cykloalkano/b/ dihydroindol- och indolsulfonamider.

Country Status (21)

Country Link
US (3) US5039670A (fi)
EP (1) EP0425906B1 (fi)
JP (1) JPH03151360A (fi)
KR (1) KR910007876A (fi)
CN (1) CN1051354A (fi)
AT (1) ATE102185T1 (fi)
AU (1) AU628665B2 (fi)
CA (1) CA2028621A1 (fi)
DE (1) DE59004764D1 (fi)
DK (1) DK0425906T3 (fi)
ES (1) ES2062250T3 (fi)
FI (1) FI905294A0 (fi)
GB (1) GB8924392D0 (fi)
HU (1) HUT57190A (fi)
IE (1) IE903869A1 (fi)
IL (1) IL96134A0 (fi)
NO (1) NO904487L (fi)
NZ (1) NZ235860A (fi)
PH (1) PH27484A (fi)
PT (1) PT95728A (fi)
ZA (1) ZA908637B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0528762B1 (de) * 1991-08-15 1997-05-07 Novartis AG N-Acyl-N-Heterocyclyl- oder Naphthylalkyl-Aminosäuren als Angiotensin II Antagonisten
DE19506739A1 (de) * 1995-02-27 1996-08-29 Bayer Ag [3-Amino]-tetrahydrocarbazol-propansäureester
US5708187A (en) * 1996-06-27 1998-01-13 Eli Lilly And Company 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta 7,6-B!indoles: New 5-HT1F agonists
WO2003097598A1 (fr) * 2002-05-16 2003-11-27 Shionogi & Co., Ltd. Composé comprenant un antagonisme du récepteur de pdg2
WO2003097042A1 (fr) * 2002-05-16 2003-11-27 Shionogi & Co., Ltd. Antagoniste de recepteur de pdg2
JP2007501284A (ja) * 2003-06-10 2007-01-25 スミスクライン ビーチャム コーポレーション テトラヒドロカルバゾール誘導体およびそれらの薬学的使用
DK1902026T3 (da) * 2005-06-24 2010-04-26 Lilly Co Eli Tetrahydrocarbazol-derivater, der kan anvendes som androgen-receptor-modulatorer (SARM)
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators
UA98777C2 (en) * 2006-11-20 2012-06-25 Эли Лилли Энд Компани Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators
CN101434571B (zh) * 2007-11-13 2012-05-30 杭州容立医药科技有限公司 环烷并[1,2-b]吲哚磺酰胺、其异构体或其盐的合成方法
PT2297100E (pt) * 2008-05-16 2013-01-24 Lilly Co Eli Moduladores dos receptores de andrógenos tetra-hidrociclopenta[b]indoles
LT3119779T (lt) 2014-03-17 2018-09-10 Idorsia Pharmaceuticals Ltd Azaindolo acto rūgšties dariniai ir jų panaudojimas kaip prostaglandino d2 receptoriaus moduliatorių
MX2018003202A (es) 2015-09-15 2018-06-08 Idorsia Pharmaceuticals Ltd Formas cristalinas.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3514696A1 (de) * 1985-04-24 1986-11-06 Bayer Ag, 5090 Leverkusen N-indolylethyl-sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
IL81325A (en) * 1986-01-23 1990-11-29 Merck Frosst Canada Inc Tetrahydrocarbazole 1-alkanoic acids and pharmaceutical compositions containing them
US4808608A (en) * 1986-01-23 1989-02-28 Merck & Co., Inc. Tetrahydrocarbazole 1-alkanoic acids, pharmaceutical compositions and use
DE3631824A1 (de) * 1986-02-21 1988-03-31 Bayer Ag Cycloalkano(1.2-b)indol-sulfonamide
US4940719A (en) * 1986-03-27 1990-07-10 Merck Frosst Canada, Inc. Tetrahydrocarbazole esters, pharmaceutical compositions and use
DE3613623A1 (de) * 1986-04-23 1987-10-29 Bayer Ag N-dihydroindolylethyl-sulfonamide

Also Published As

Publication number Publication date
HUT57190A (en) 1991-11-28
NO904487L (no) 1991-05-02
PH27484A (en) 1993-07-23
IE903869A1 (en) 1991-05-08
IL96134A0 (en) 1991-07-18
EP0425906B1 (de) 1994-03-02
DK0425906T3 (da) 1994-04-11
EP0425906A2 (de) 1991-05-08
ATE102185T1 (de) 1994-03-15
PT95728A (pt) 1991-09-13
NO904487D0 (no) 1990-10-17
US5096897A (en) 1992-03-17
NZ235860A (en) 1992-09-25
ES2062250T3 (es) 1994-12-16
AU6384890A (en) 1991-06-20
KR910007876A (ko) 1991-05-30
CA2028621A1 (en) 1991-05-01
ZA908637B (en) 1991-08-28
DE59004764D1 (de) 1994-04-07
AU628665B2 (en) 1992-09-17
EP0425906A3 (en) 1992-01-22
JPH03151360A (ja) 1991-06-27
US5374647A (en) 1994-12-20
US5039670A (en) 1991-08-13
GB8924392D0 (en) 1989-12-20
CN1051354A (zh) 1991-05-15
HU906925D0 (en) 1991-05-28

Similar Documents

Publication Publication Date Title
NO904487L (no) Substituerte cykloalkano/b/dihydroindol- og indolsulfonamider.
FR2645866B1 (fr) Nouvelles lipopolyamines, leur preparation et leur emploi
MY106250A (en) Azolylmethylcyclopentane benzylidene fungicide.
HUT66370A (en) Polymers containing diester units and process for producing thereof
MXPA95001266A (es) Derivados de quinona y uso farmacologico.
MX9804471A (es) Unidades monomericas utiles para reducir el modulo de los hidrogeles de silicona.
LU90074I2 (fr) Chlorhydrate d'irinotécan trihydraté et ses dérivés pharmaceutiquement acceptables (Campto)
CA2067184A1 (en) New linker for bioactive agents
DE69631599D1 (de) Addtionspolymere von polycycycloolefinen mit silyl-funktionellen gruppen
GEP20002210B (en) Acridine Derivatives
ES2001586A6 (es) Un procedimiento para producir un complejo de diamina platino (ii)
NO955326L (no) Isokinolinderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse
CA2017931A1 (en) Process for the preparation of titanocenes containing o,o'-difluoroaryl ligands
IL105111A (en) SEMI-SYNTHETIC GLYCOSAMINOGLYCANS CONTAINING a-L- GALACTURONIC ACID SUBSTITUTED WITH NUCLEOPHILIC RADICALS IN POSITION 3 AND THEIR PREPARATION
MY104150A (en) Treatment of cognitive and behavioral disorders associated with aging and with dementia syndromes
DE3484426D1 (en) Poly(arylenether).
IE41375B1 (en) Diethyl hydroxymethylphosphonate esters and their preparation
MY101309A (en) Benzoylureas, and their production and use
EP0308910A3 (en) Novel platinum complex
WO1990010639A3 (en) New 3'-(4-morpholinyl)- and 3'-(2-methoxy-4-morpholinyl)- anthracycline derivatives
ZA869476B (en) Branched polycarbonates containing single-ring aromatic compounds
DE69023288D1 (de) Carbonylgruppen und unterschiedlich alkylierte, tertiäre Aminogruppen aufweisende Polyphosphazenderivate.
MY131054A (en) "piperazine cyanurate and polymer compositions comprising it"
IE41217L (en) Quinonoxime - acylhydrazone fungicides
CA2044493A1 (fr) Acrylates et methacrylates phospho-soufres, leur procede de preparation et nouveaux polymeres en derivant

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: BAYER AKTIENGESELLSCHAFT